Comosystems was founded on a simple principle: for EMF technology to be worth doing, it has to be proven by independent researchers and make a measurable, statistically significant improvement to the biomarkers that EMFs disrupt.
Shop the range
Anything that genuinely blocked EMFs would also stop your phone or Wi-Fi working. If a device still functions normally, the EMFs are still reaching you.
Each CMO contains a programmed microcrystalline solution activated by incoming radiation. It generates a 12 Hz hyper-weak compensation signal that resonates with and resets ion receptors within your cells — helping the body cope with exposure across old and new frequencies alike.
A range of studies in both people and animals demonstrate measurable improvements in parameters substantially disrupted by EMFs. Testing methods referenced by Comosystems include SAR measurement, cymascopy, infrared spectroscopy and SQUID registration.
Full scientific publications, videos and testing methodology are documented on the international Comosystems research pages.
In 2011 the World Health Organisation classified radiofrequency EMFs as Class 2B “possible carcinogens”.
Lloyd's of London underwriters excluded EMF-related illness from health cover in 2015.
Developing bodies and dividing DNA are more susceptible — and effects may take decades to appear.
Bring independently tested CMO technology into your home or workplace.
Explore the range →